Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
The report details the trend, potential and market size of Immune Checkpoint Blockers market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.
The first part (Chapter1-7) mainly covers the qualitative analysis of Immune Checkpoint Blockersmarket, defines the market attractiveness level of Immune Checkpoint Blockers market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.
The second part (Chapter8-12), based on the segmentation of Immune Checkpoint Blockers industry, describes the types of Immune Checkpoint Blockers market, the applications of major players and the market size, and deeply analyzes the current situation of the global Immune Checkpoint Blockers market and the development prospects and opportunities of Immune Checkpoint Blockers industry.
The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.
As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Immune Checkpoint Blockers market in Chapter 13.
By Player:
Roche
Bristol Myers Squibb
Merck
AstraZeneca
By Type:
Anti-PD-L1 Drug
Anti-PD-1 Drug
CTLA4
By End-User:
Lung Cancer
Colorectal Cancer
Breast Cancer
Prostate Cancer
Melanoma
Blood Cancers
By Geography:
-
United States
-
Europe
-
China
-
Japan
-
India
-
South Korea
TABLE OF CONTENT
1 Introduction
-
1.1 Market Definition
-
1.2 Market Segment Analysis
-
1.3 Market Size 2022
-
1.4 Immune Checkpoint Blockers Market Outlook: Forecast for 2022 - 2028
-
1.5 Pricing Analysis
2 Executive Summary
3 Immune Checkpoint Blockers Market Lineage Outlook
-
3.1 Parent Market Outlook
-
3.2 Related/Ancillary Market Outlook
-
3.3 Penetration & Growth Prospect Mapping, 2022
4 Market Analysis Tools: Porter's Five Forces
-
4.1 Supplier Power
-
4.2 Buyer Power
-
4.3 Substitution Threat
-
4.4 Threat of New Entrants
-
4.5 Competitive Rivalry
5 Immune Checkpoint Blockers Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)
-
5.1 Political/Legal Landscape
-
5.2 Economic Landscape
-
5.3 Social Landscape
-
5.4 Technology Landscape
6 Immune Checkpoint Blockers Market - Value Chain Analysis
-
6.1 Industry's Value Chain Analysis
-
6.2 Product Life Cycle
-
6.3 User Perspective Analysis
7 Region and Country-wise Immune Checkpoint Blockers Market Analysis and Outlook to 2022
-
7.1 Global Immune Checkpoint Blockers Consumption (2017-2022)
-
7.2 United States Immune Checkpoint Blockers Consumption (2017-2022)
-
7.3 Europe Immune Checkpoint Blockers Consumption (2017-2022)
-
7.4 China Immune Checkpoint Blockers Consumption (2017-2022)
-
7.5 Japan Immune Checkpoint Blockers Consumption (2017-2022)
-
7.6 India Immune Checkpoint Blockers Consumption (2017-2022)
-
7.7 South Korea Immune Checkpoint Blockers Consumption (2017-2022)
8 Region and Country-wise Immune Checkpoint Blockers Market Analysis and Outlook to 2028
-
8.1 Global Immune Checkpoint Blockers Consumption Forecast (2022-2028)
-
8.2 United States Immune Checkpoint Blockers Consumption Forecast (2022-2028)
-
8.3 Europe Immune Checkpoint Blockers Consumption Forecast (2022-2028)
-
8.4 China Immune Checkpoint Blockers Consumption Forecast (2022-2028)
-
8.5 Japan Immune Checkpoint Blockers Consumption Forecast (2022-2028)
-
8.6 India Immune Checkpoint Blockers Consumption Forecast (2022-2028)
-
8.7 South Korea Immune Checkpoint Blockers Consumption Forecast (2022-2028)
9 Global Immune Checkpoint Blockers Market Outlook by Types and Applications to 2022
-
9.1 Global Immune Checkpoint Blockers Consumption and Growth Rate by Type (2017-2022)
-
9.1.1 Global Anti-PD-L1 Drug Consumption and Growth Rate (2017-2022)
-
9.1.2 Global Anti-PD-1 Drug Consumption and Growth Rate (2017-2022)
-
9.1.3 Global CTLA4 Consumption and Growth Rate (2017-2022)
-
9.2 Global Immune Checkpoint Blockers Consumption and Growth Rate by Application (2017-2022)
-
9.2.1 Global Lung Cancer Consumption and Growth Rate (2017-2022)
-
9.2.2 Global Colorectal Cancer Consumption and Growth Rate (2017-2022)
-
9.2.3 Global Breast Cancer Consumption and Growth Rate (2017-2022)
-
9.2.4 Global Prostate Cancer Consumption and Growth Rate (2017-2022)
-
9.2.5 Global Melanoma Consumption and Growth Rate (2017-2022)
-
9.2.6 Global Blood Cancers Consumption and Growth Rate (2017-2022)
10 Global Immune Checkpoint Blockers Market Outlook by Types and Applications to 2028
-
10.1 Global Immune Checkpoint Blockers Consumption Forecast and Growth Rate by Type (2022-2028)
-
10.1.1 Global Anti-PD-L1 Drug Consumption Forecast and Growth Rate (2022-2028)
-
10.1.2 Global Anti-PD-1 Drug Consumption Forecast and Growth Rate (2022-2028)
-
10.1.3 Global CTLA4 Consumption Forecast and Growth Rate (2022-2028)
-
10.2 Global Immune Checkpoint Blockers Consumption Forecast and Growth Rate by Application (2022-2028)
-
10.2.1 Global Lung Cancer Consumption Forecast and Growth Rate (2022-2028)
-
10.2.2 Global Colorectal Cancer Consumption Forecast and Growth Rate (2022-2028)
-
10.2.3 Global Breast Cancer Consumption Forecast and Growth Rate (2022-2028)
-
10.2.4 Global Prostate Cancer Consumption Forecast and Growth Rate (2022-2028)
-
10.2.5 Global Melanoma Consumption Forecast and Growth Rate (2022-2028)
-
10.2.6 Global Blood Cancers Consumption Forecast and Growth Rate (2022-2028)
11 Global Immune Checkpoint Blockers Import and Export Analysis (Top 5 Countries)
-
11.1 Global Immune Checkpoint Blockers Import by Region (Top 5 Countries) (2017-2028)
-
11.2 Global Immune Checkpoint Blockers Export by Region (Top 5 Countries) (2017-2028)
12 Coronavirus Disease (COVID-19) Impact
-
12.1 Industry Impact Analysis
-
12.2 Immune Checkpoint Blockers Market Outlook to 2028 - COVID-19 Affected Forecasts
13 Competition Matrix
-
13.1 Target Markets
-
13.2 Comprehensive Analysis of Products in Competitive Markets
14 Global Immune Checkpoint Blockers Market Competitive Analysis
-
14.1 Roche
-
14.1.1 Roche Company Details
-
14.1.2 Roche Immune Checkpoint Blockers Sales, Price, Value and Gross Profit (2017-2022)
-
14.1.3 Roche Immune Checkpoint Blockers Product and Service
-
14.2 Bristol Myers Squibb
-
14.2.1 Bristol Myers Squibb Company Details
-
14.2.2 Bristol Myers Squibb Immune Checkpoint Blockers Sales, Price, Value and Gross Profit (2017-2022)
-
14.2.3 Bristol Myers Squibb Immune Checkpoint Blockers Product and Service
-
14.3 Merck
-
14.3.1 Merck Company Details
-
14.3.2 Merck Immune Checkpoint Blockers Sales, Price, Value and Gross Profit (2017-2022)
-
14.3.3 Merck Immune Checkpoint Blockers Product and Service
-
14.4 AstraZeneca
-
14.4.1 AstraZeneca Company Details
-
14.4.2 AstraZeneca Immune Checkpoint Blockers Sales, Price, Value and Gross Profit (2017-2022)
-
14.4.3 AstraZeneca Immune Checkpoint Blockers Product and Service
15 Appendix
TABLE OF CHARTS
-
Table Definition of Immune Checkpoint Blockers
-
Figure Immune Checkpoint Blockers Picture
-
Table Global Immune Checkpoint Blockers Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Immune Checkpoint Blockers Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Immune Checkpoint Blockers Market: Year-over-year Growth 2022 - 2028 (%)
-
Table Parent Market Analysis
-
Figure Parent Market Price
-
Table Related/Ancillary Market Outlook Analysis
-
Table Supplier Power Analysis
-
Table Buyer Power Analysis
-
Table Substitution Threat Analysis
-
Table Threat of New Entrants Analysis
-
Table Competitive Rivalry Analysis
-
Figure Global Immune Checkpoint Blockers Consumption by Country (2017-2022)
-
Figure United States Immune Checkpoint Blockers Consumption and Growth Rate (2017-2022)
-
Table Europe Immune Checkpoint Blockers Consumption and Growth Rate (2017-2022)
-
Figure China Immune Checkpoint Blockers Consumption and Growth Rate (2017-2022)
-
Figure Japan Immune Checkpoint Blockers Consumption and Growth Rate (2017-2022)
-
Figure India Immune Checkpoint Blockers Consumption and Growth Rate (2017-2022)
-
Figure South Korea Immune Checkpoint Blockers Consumption and Growth Rate (2017-2022)
-
Figure Global Immune Checkpoint Blockers Consumption Forecast by Country (2022-2028)
-
Figure United States Immune Checkpoint Blockers Consumption Forecast and Growth Rate (2022-2028)
-
Table Europe Immune Checkpoint Blockers Consumption Forecast and Growth Rate (2022-2028)
-
Figure China Immune Checkpoint Blockers Consumption Forecast and Growth Rate (2022-2028)
-
Figure Japan Immune Checkpoint Blockers Consumption Forecast and Growth Rate (2022-2028)
-
Figure India Immune Checkpoint Blockers Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Korea Immune Checkpoint Blockers Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Anti-PD-L1 Drug Consumption and Growth Rate (2017-2022)
-
Figure Global Anti-PD-1 Drug Consumption and Growth Rate (2017-2022)
-
Figure Global CTLA4 Consumption and Growth Rate (2017-2022)
-
Figure Global Lung Cancer Consumption and Growth Rate (2017-2022)
-
Figure Global Colorectal Cancer Consumption and Growth Rate (2017-2022)
-
Figure Global Breast Cancer Consumption and Growth Rate (2017-2022)
-
Figure Global Prostate Cancer Consumption and Growth Rate (2017-2022)
-
Figure Global Melanoma Consumption and Growth Rate (2017-2022)
-
Figure Global Blood Cancers Consumption and Growth Rate (2017-2022)
-
Figure Global Anti-PD-L1 Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Anti-PD-1 Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global CTLA4 Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Lung Cancer Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Colorectal Cancer Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Breast Cancer Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Prostate Cancer Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Melanoma Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Blood Cancers Consumption Forecast and Growth Rate (2022-2028)
-
Table Global Immune Checkpoint Blockers Import by Region (Top 5 Countries) (2017-2028)
-
Table Global Immune Checkpoint Blockers Export by Region (Top 5 Countries) (2017-2028)
-
Table Roche (Foundation Year, Company Profile and etc.)
-
Table Roche Immune Checkpoint Blockers Sales, Price, Value and Gross Profit (2017-2022)
-
Table Roche Immune Checkpoint Blockers Product and Service
-
Table Bristol Myers Squibb (Foundation Year, Company Profile and etc.)
-
Table Bristol Myers Squibb Immune Checkpoint Blockers Sales, Price, Value and Gross Profit (2017-2022)
-
Table Bristol Myers Squibb Immune Checkpoint Blockers Product and Service
-
Table Merck (Foundation Year, Company Profile and etc.)
-
Table Merck Immune Checkpoint Blockers Sales, Price, Value and Gross Profit (2017-2022)
-
Table Merck Immune Checkpoint Blockers Product and Service
-
Table AstraZeneca (Foundation Year, Company Profile and etc.)
-
Table AstraZeneca Immune Checkpoint Blockers Sales, Price, Value and Gross Profit (2017-2022)
-
Table AstraZeneca Immune Checkpoint Blockers Product and Service
-
